Cashu | News | CRSP

HomeWatchlistNewsSignalsPicks

DJI

+1.05%

SPX

+1.03%

IXIC

+1.20%

FTSE

+0.30%

N225

+0.50%

AXJO

-0.27%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest CRISPR Therapeutics AG News

CRISPR Market is expected to generate a revenue of USD 12.78 Billion by 2032, Globally, at 15.85% CAGR: Verified Market Research

Feature Image for interests on Biotechnology, CryptoCurrency, ETF, FX from prnewswire.com

The World's First Genetically Modified Spider Could Change The Future Of Military Tech

Feature Image for interests on Benzinga, Crispr, Healthcare, Navy from benzinga.com

Desperately Ill Baby Successfully Treated With First-Ever CRISPR Gene Editing Therapy

Feature Image for interests on Crispr, Gene Editing, Healthcare, Medical Research from huffpost.com

World's First Patient Treated with Personalized CRISPR Gene Editing Therapy at Children's Hospital of Philadelphia

Feature Image for interests on Children, Clinical Trials & Medical Discoveries, Health Care & Hospitals, Healthcare from prnewswire.com

Cathie Wood's Wednesday Wisdom? Bets On Airbnb's Platform Expansion, Dumps Palantir At Peak

Feature Image for interests on $Btc, $Sol, Abnb, Ark Invest from benzinga.com

Cathie Wood Dumps Palantir As Stock Touches Peak Prices, Bails On Soaring Flying-Taxi Maker Archer Aviation

Feature Image for interests on Achr, Archer Aviation, Ark Invest, Ark Invest Etfs from benzinga.com

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst

Feature Image for interests on Analyst Color, Analyst Ratings, Benzinga, Biotech from benzinga.com

about 1 month ago

Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation

Feature Image for interests on Analyst Color, Analyst Ratings, Bbc, Benzinga from benzinga.com

about 1 month ago

These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results

Feature Image for interests on Analyst Ratings, Benzinga, Crsp, Earnings from benzinga.com

about 1 month ago

Cathie Wood Sells Palantir Shares Worth $2.65 Million Ahead Of Earnings, Doubles Down On This Chip Giant

about 1 month ago

Latest Cashu News

CRISPR Therapeutics AG: Market Growth Driven by Advances in Gene Editing and Precision Medicine

CRISPR Therapeutics AG Poised for Growth in Expanding CRISPR Market by 2032

CRISPR Therapeutics AG Positioned for Growth in Expanding Gene Editing Market

Stocks

Health Care

crsp

CRISPR Therapeutics AG

CRSP

+3.35 (+8.70%)

41.925

USD

At close at Jun 06, 20:40 UTC